Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 132Breast 86Lymphoid 39Plasma cell 33Sarcoma 20Other hematologic neoplasm 11Genitourinary 11Gastrointestinal 9Other solid neoplasm 8Tumor-Agnostic 7Thoracic 7Dermatologic 5CNS 4Head & Neck 2Other neoplasm 1NET 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Unrecognized Condition 1

Interventions

Cyclophosphamide 13Biopsy 13fludarabine phosphate 9Whole-Body Irradiation 9Surveys and Questionnaires 9Peripheral Blood Stem Cell Transplantation 9Busulfan 9Polymerase Chain Reaction 7Mycophenolic Acid 7Early Intervention, Educational 7Tacrolimus 6Gene Expression Profiling 6Educational Status 6Colposcopy 6Carboplatin 6fludarabine 5Paclitaxel 5Microarray Analysis 5Methotrexate 5Methods 5Melphalan 5Immunohistochemistry 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
liposomal doxorubicin × Other neoplasm × Clear all
NCT04213612 2019-12-30

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Sun Yat-sen University

Phase 1 Unknown
21 enrolled
Other neoplasm

Unrecognized Condition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡